Werner Brannath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Werner Brannath has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Gernot Wassmer
University of Cologne
12 shared publications - Lasse Fischer
Competence Center for Clinical Trials Bremen, University of Bremen, Bremen, Germany
6 shared publications - Martin Scharpenberg
Competence Center for Clinical Trials Bremen, University of Bremen, Bremen, Germany
5 shared publications - Gernot Wassmer
University of Cologne
4 shared publications - Marta Bofill Roig
Department of Statistics and Operations Research and Institute for Research and Innovation in Health (IRIS) Universitat Politécnica de Catalunya – BarcelonaTech (UPC) Barcelona Spain
4 shared publications - Remi Luschei
Competence Center for Clinical Trials Bremen Institute for Statistics Competence Center for Clinical Trials Bremen Institute for Statistics University of Bremen University of Bremen
4 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (20-22)
Family‐Wise Error Rate Control in Clinical Trials With Overlapping Populations
We consider clinical trials with multiple, overlapping patient populations that test multiple treatment policies specifically tailored to these populations. Such designs may lead to multiplicity issues, as false statements will affect several populations. For type I error control, often the family‐wise error rate (FWER) is controlled, which is the probability to reject at least one true null hypothesis. If the joint distribution of the test statistics is known, the FWER level can be exhausted by determining critical values or adjusted ‐levels. The adjustment is typically done under the common ANOVA assumptions. However, the performed tests are then only valid under the rather strong assumption of homogeneous null effects, that is, when the null hypothesis applies to all subpopulations and their intersections. We show that under cancelling null effects, when heterogeneous effects cancel out in some or all subpopulations, this procedure does not provide FWER control. We also suggest different alternatives and compare them in terms of FWER control and their power.
- 25 August 2026
- Published by Wiley in Statistics in Medicine
- Vol. 45 (20-22)
Open AccessFamily‐Wise Error Rate Control in Clinical Trials With Overlapping Populations
We consider clinical trials with multiple, overlapping patient populations that test multiple treatment policies specifically tailored to these populations. Such designs may lead to multiplicity issues, as false statements will affect several populations. For type I error control, often the family‐wise error rate (FWER) is controlled, which is the probability to reject at least one true null hypothesis. If the joint distribution of the test statistics is known, the FWER level can be exhausted by determining critical values or adjusted ‐levels. The adjustment is typically done under the common ANOVA assumptions. However, the performed tests are then only valid under the rather strong assumption of homogeneous null effects, that is, when the null hypothesis applies to all subpopulations and their intersections. We show that under cancelling null effects, when heterogeneous effects cancel out in some or all subpopulations, this procedure does not provide FWER control. We also suggest different alternatives and compare them in terms of FWER control and their power.
- Open Access
- 19 August 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (8) , e0006872
Overlooked and undertreated: Hearing loss among individuals with intellectual disabilities – A German cohort study
People with intellectual disabilities (ID) are 5–10 times more likely to have hearing loss than the general population, yet it often remains undetected and untreated. To address this gap, the study HörGeist examined the feasibility, outcomes, barriers, and costs of an outreach program with hearing screening, diagnostics, intervention, and monitoring in everyday environments to implement a universal program in Germany. This report outlines ear and hearing care status before and after inclusion in the program and compares outcomes with standard care and a clinic-based invitation model. In a population-based, age-stratified cohort study, 1053 participants with ID (37% female; age 1–90 years) received screening and reference measurements in nurseries, schools, workplaces, and residences. When screening indicated possible hearing loss, on-site diagnostics and therapy were provided or referrals issued. A comparison cohort of 141 individuals with ID was invited to a clinic for identical procedures; none participated. All procedures were repeated after 1 year. Hearing loss was known in 14% of outreach participants at study entry; 8.7% had previously received hearing aids, but fewer than half (4.3%) used them. The program diagnosed hearing loss in 44% of participants, with 70% previously undiagnosed. After screening, 27% received therapy recommendations, but only 37% adhered to them (30% for hearing-aid prescriptions). Undertreated hearing loss declined only slightly, from 43% to 38%, over time. Major barriers included refusal by caregivers (31%) and participants (33%), often appearing to be linked to limited awareness of the treatability and consequences of hearing loss, as well as time and staff shortages. Outreach hearing screening programs are highly necessary, feasible, and effective in detecting hearing loss in people with ID, but substantial care gaps persist. Implementation requires public and professional awareness and rehabilitation strategies that include hearing and communication training and actively involve individuals with ID and their caregivers.
- 19 August 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (8) , e0006872
Open AccessOverlooked and undertreated: Hearing loss among individuals with intellectual disabilities – A German cohort study
People with intellectual disabilities (ID) are 5–10 times more likely to have hearing loss than the general population, yet it often remains undetected and untreated. To address this gap, the study HörGeist examined the feasibility, outcomes, barriers, and costs of an outreach program with hearing screening, diagnostics, intervention, and monitoring in everyday environments to implement a universal program in Germany. This report outlines ear and hearing care status before and after inclusion in the program and compares outcomes with standard care and a clinic-based invitation model. In a population-based, age-stratified cohort study, 1053 participants with ID (37% female; age 1–90 years) received screening and reference measurements in nurseries, schools, workplaces, and residences. When screening indicated possible hearing loss, on-site diagnostics and therapy were provided or referrals issued. A comparison cohort of 141 individuals with ID was invited to a clinic for identical procedures; none participated. All procedures were repeated after 1 year. Hearing loss was known in 14% of outreach participants at study entry; 8.7% had previously received hearing aids, but fewer than half (4.3%) used them. The program diagnosed hearing loss in 44% of participants, with 70% previously undiagnosed. After screening, 27% received therapy recommendations, but only 37% adhered to them (30% for hearing-aid prescriptions). Undertreated hearing loss declined only slightly, from 43% to 38%, over time. Major barriers included refusal by caregivers (31%) and participants (33%), often appearing to be linked to limited awareness of the treatability and consequences of hearing loss, as well as time and staff shortages. Outreach hearing screening programs are highly necessary, feasible, and effective in detecting hearing loss in people with ID, but substantial care gaps persist. Implementation requires public and professional awareness and rehabilitation strategies that include hearing and communication training and actively involve individuals with ID and their caregivers.
- Open Access
- 7 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluation of Digital Therapeutics: Tutorial on Adaptive Design Methods (Preprint)
UNSTRUCTURED Software-based digital therapeutics (DTx) are increasingly integrated into routine health care. To enable early access for patients to innovative interventions, there are options for early market access/provisional reimbursement of DTx within regulatory frameworks, such as the German Digital Health Applications (DiGA) fast-track pathway, implemented by the Federal Institute for Drugs and Medical Devices (BfArM). They highlight both the opportunities and challenges of generating robust evidence under conditions of early market access (provisional registration for reimbursement). In particular, the widespread separation of pilot studies (for provisional registration) and confirmatory studies (for permanent registration) in such frameworks can lead to duplicate data collection, inefficient resource use, and practical difficulties in meeting evidence requirements within constrained timelines. This tutorial provides an accessible introduction to adaptive clinical trial designs and demonstrates their application to the evaluation of DTx in registration studies such as the German fast-track pathway. The focus is on the conditional-error-function approach. We explain how this approach enables integrating the pilot and confirmatory stages into a single, coherent trial design while maintaining strict control of type I error despite possible design modifications at interim analyses. This includes sample size recalculations. When deciding to conduct a single two-stage adaptive study, the pilot-stage data can be used for provisional registration, and the data from both stages (pilot and confirmatory) can be used for permanent registration. In addition, the tutorial addresses common complexities in DTx evaluation, including multiple relevant endpoints and heterogeneity across patient subgroups. We introduce methods for handling multiplicity, such as Bonferroni adjustments and the closed testing principle. We illustrate how these principles can be incorporated into adaptive designs to support flexible endpoint or subgroup selection after some data have been collected, without compromising statistical validity. Practical examples, inspired by real-world registration studies in the DiGA context, demonstrate how adaptive designs can improve efficiency by reducing overall sample size requirements, shortening study timelines, and enabling a more informative use of pilot-stage data. Beyond the German setting, we discuss the broader applicability of adaptive designs to international DTx evaluation frameworks. Many of these frameworks face similar challenges in balancing timely access to innovation with the need for robust confirmatory evidence. By translating established statistical methodologies into a form accessible to digital health researchers, developers, and regulators, this tutorial aims to support the adoption of more efficient and flexible evaluation strategies. In conclusion, adaptive trial designs represent a powerful, statistically valid, and practical approach for improving the evaluation of DTx.
- 7 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluation of Digital Therapeutics: Tutorial on Adaptive Design Methods (Preprint)
UNSTRUCTURED Software-based digital therapeutics (DTx) are increasingly integrated into routine health care. To enable early access for patients to innovative interventions, there are options for early market access/provisional reimbursement of DTx within regulatory frameworks, such as the German Digital Health Applications (DiGA) fast-track pathway, implemented by the Federal Institute for Drugs and Medical Devices (BfArM). They highlight both the opportunities and challenges of generating robust evidence under conditions of early market access (provisional registration for reimbursement). In particular, the widespread separation of pilot studies (for provisional registration) and confirmatory studies (for permanent registration) in such frameworks can lead to duplicate data collection, inefficient resource use, and practical difficulties in meeting evidence requirements within constrained timelines. This tutorial provides an accessible introduction to adaptive clinical trial designs and demonstrates their application to the evaluation of DTx in registration studies such as the German fast-track pathway. The focus is on the conditional-error-function approach. We explain how this approach enables integrating the pilot and confirmatory stages into a single, coherent trial design while maintaining strict control of type I error despite possible design modifications at interim analyses. This includes sample size recalculations. When deciding to conduct a single two-stage adaptive study, the pilot-stage data can be used for provisional registration, and the data from both stages (pilot and confirmatory) can be used for permanent registration. In addition, the tutorial addresses common complexities in DTx evaluation, including multiple relevant endpoints and heterogeneity across patient subgroups. We introduce methods for handling multiplicity, such as Bonferroni adjustments and the closed testing principle. We illustrate how these principles can be incorporated into adaptive designs to support flexible endpoint or subgroup selection after some data have been collected, without compromising statistical validity. Practical examples, inspired by real-world registration studies in the DiGA context, demonstrate how adaptive designs can improve efficiency by reducing overall sample size requirements, shortening study timelines, and enabling a more informative use of pilot-stage data. Beyond the German setting, we discuss the broader applicability of adaptive designs to international DTx evaluation frameworks. Many of these frameworks face similar challenges in balancing timely access to innovation with the need for robust confirmatory evidence. By translating established statistical methodologies into a form accessible to digital health researchers, developers, and regulators, this tutorial aims to support the adoption of more efficient and flexible evaluation strategies. In conclusion, adaptive trial designs represent a powerful, statistically valid, and practical approach for improving the evaluation of DTx.
- Open Access
- 2 July 2026
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 35 (8) , 1693-1708
Asymptotic online FWER control for dependent test statistics
In online multiple testing, an a priori unknown number of hypotheses are tested sequentially, that is, at each time point, a test decision for the current hypothesis has to be made using only the data available so far. Although many powerful test procedures have been developed for online error control in recent years, most of them are designed solely for independent or at most locally dependent test statistics. In this work, we provide a new framework for deriving online multiple test procedures that ensure asymptotical (with respect to the sample size) control of the familywise error rate, regardless of the dependence structure between test statistics. In this context, we give a few concrete examples of such test procedures and discuss their properties. Furthermore, we conduct a simulation study in which the type I error control of these test procedures is also confirmed for a finite sample size, and a gain in power is indicated.
- 2 July 2026
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 35 (8) , 1693-1708
Open AccessAsymptotic online FWER control for dependent test statistics
In online multiple testing, an a priori unknown number of hypotheses are tested sequentially, that is, at each time point, a test decision for the current hypothesis has to be made using only the data available so far. Although many powerful test procedures have been developed for online error control in recent years, most of them are designed solely for independent or at most locally dependent test statistics. In this work, we provide a new framework for deriving online multiple test procedures that ensure asymptotical (with respect to the sample size) control of the familywise error rate, regardless of the dependence structure between test statistics. In this context, we give a few concrete examples of such test procedures and discuss their properties. Furthermore, we conduct a simulation study in which the type I error control of these test procedures is also confirmed for a finite sample size, and a gain in power is indicated.
- Open Access
A prediction interval for the population-wise error rate
We construct an asymptotic prediction interval for the population-wise error rate (PWER), which is a multiple type I error criterion for clinical trials with overlapping patient populations. The PWER is the probability that a randomly selected patient will receive an ineffective treatment. It must usually be estimated due to unknown population strata sizes, such that only an estimate can be controlled at the given significance level. We apply the delta method to find a prediction interval for the resulting true PWER, we demonstrate by simulations that the interval has the required coverage probability, and illustrate the approach with real data examples.
Open AccessA prediction interval for the population-wise error rate
We construct an asymptotic prediction interval for the population-wise error rate (PWER), which is a multiple type I error criterion for clinical trials with overlapping patient populations. The PWER is the probability that a randomly selected patient will receive an ineffective treatment. It must usually be estimated due to unknown population strata sizes, such that only an estimate can be controlled at the given significance level. We apply the delta method to find a prediction interval for the resulting true PWER, we demonstrate by simulations that the interval has the required coverage probability, and illustrate the approach with real data examples.
- Open Access
- 16 January 2026
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 70 (4) , 384-394
Clinical Diagnostics After Failed Hearing Screening in People With Intellectual Disabilities Do Not Often Take Place
Background: Individuals with intellectual disabilities are at higher risk of undiagnosed or inadequately treated hearing loss. This situation requires easily accessible hearing screening, diagnostics and intervention programmes in the living environment, i.e., in nurseries, schools, workplaces and homes. However, a full audiometric assessment is not always possible in nonclinical settings. The multicentre cohort study HörGeist investigated the effectiveness, feasibility and costs of an outreach programme of repeated hearing screening, diagnostics, intervention and monitoring of children, adolescents and adults with intellectual disabilities in their living environment in comparison with an invitation‐only programme comprising a control cohort in a clinical setting and with standard care. This paper reports on the HörGeist substudy of the outreach cohort, focusing on participants referred for ‘external’ diagnostics in clinical settings after failing on‐site screening, and evaluating both referral uptake and outcomes. Methods: Because none of the 141 individuals in the control cohort provided informed consent to attend the programme in a clinical setting, our results pertain solely to the outcomes and feasibility within the outreach cohort. All of the 1053 participants in the outreach cohort who failed the hearing screening tests underwent full on‐site audiometric assessment. Where on‐site screening and/or diagnostics were not feasible, referrals to external medical institutions were provided. Participants who were referred to external diagnostics were tracked via telephone interviews using a questionnaire and asked about their utilisation and the outcome of diagnostics. In cases where referrals were not pursued, reasons for non‐compliance were recorded. Results: A referral for external diagnostics was received by 262 of the 1053 participants of the outreach cohort. Of these, 19 dropped out of the study. Of the 248 referrals received by the remaining 243 participants, 93 (37.5%) were attended and 155 (62.5%) were not. The main reasons for non‐attendance were ‘no attempt to arrange an appointment’ (32.9%), ‘refusal by caregivers’ (23.2%) and ‘refusal by participants’ (18.1%). Approximately 4% did not receive an appointment for external diagnostics. Referral uptake declined with age, with uptake rates of 50.8% in young children, 41.3% in school‐aged participants and 24.7% in adults. Telephone tracking of a subsample of 48 participants who primarily did not attend for external assessment led to further clinical diagnostics in eight cases (16.7%). Conclusions: In order to achieve an improvement in the hearing situation of people with intellectual disabilities, a screening, diagnostic and intervention programme in their living environment seems both feasible and beneficial. However, reliable assessment of the hearing status of the participants of such a programme requires education of participants, caregivers and medical professionals regarding its necessity and fostering of close collaboration with healthcare providers in outpatient and clinical settings. Trial Registration: German Clinical Trials Register (DRKS‐ID: DRKS00024804)
- 16 January 2026
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 70 (4) , 384-394
Open AccessClinical Diagnostics After Failed Hearing Screening in People With Intellectual Disabilities Do Not Often Take Place
Background: Individuals with intellectual disabilities are at higher risk of undiagnosed or inadequately treated hearing loss. This situation requires easily accessible hearing screening, diagnostics and intervention programmes in the living environment, i.e., in nurseries, schools, workplaces and homes. However, a full audiometric assessment is not always possible in nonclinical settings. The multicentre cohort study HörGeist investigated the effectiveness, feasibility and costs of an outreach programme of repeated hearing screening, diagnostics, intervention and monitoring of children, adolescents and adults with intellectual disabilities in their living environment in comparison with an invitation‐only programme comprising a control cohort in a clinical setting and with standard care. This paper reports on the HörGeist substudy of the outreach cohort, focusing on participants referred for ‘external’ diagnostics in clinical settings after failing on‐site screening, and evaluating both referral uptake and outcomes. Methods: Because none of the 141 individuals in the control cohort provided informed consent to attend the programme in a clinical setting, our results pertain solely to the outcomes and feasibility within the outreach cohort. All of the 1053 participants in the outreach cohort who failed the hearing screening tests underwent full on‐site audiometric assessment. Where on‐site screening and/or diagnostics were not feasible, referrals to external medical institutions were provided. Participants who were referred to external diagnostics were tracked via telephone interviews using a questionnaire and asked about their utilisation and the outcome of diagnostics. In cases where referrals were not pursued, reasons for non‐compliance were recorded. Results: A referral for external diagnostics was received by 262 of the 1053 participants of the outreach cohort. Of these, 19 dropped out of the study. Of the 248 referrals received by the remaining 243 participants, 93 (37.5%) were attended and 155 (62.5%) were not. The main reasons for non‐attendance were ‘no attempt to arrange an appointment’ (32.9%), ‘refusal by caregivers’ (23.2%) and ‘refusal by participants’ (18.1%). Approximately 4% did not receive an appointment for external diagnostics. Referral uptake declined with age, with uptake rates of 50.8% in young children, 41.3% in school‐aged participants and 24.7% in adults. Telephone tracking of a subsample of 48 participants who primarily did not attend for external assessment led to further clinical diagnostics in eight cases (16.7%). Conclusions: In order to achieve an improvement in the hearing situation of people with intellectual disabilities, a screening, diagnostic and intervention programme in their living environment seems both feasible and beneficial. However, reliable assessment of the hearing status of the participants of such a programme requires education of participants, caregivers and medical professionals regarding its necessity and fostering of close collaboration with healthcare providers in outpatient and clinical settings. Trial Registration: German Clinical Trials Register (DRKS‐ID: DRKS00024804)
- Open Access
- 14 November 2025
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 35 (1) , 101-117
Informative simultaneous confidence intervals for graphical test procedures
Simultaneous confidence intervals that are compatible with a given closed test procedure are often non-informative. More precisely, for a one-sided null hypothesis, the bound of the simultaneous confidence interval can stick to the border of the null hypothesis, irrespective of how far the point estimate deviates from the null hypothesis. This has been illustrated for the Bonferroni-Holm and fall-back procedures, for which alternative simultaneous confidence intervals have been suggested, that are free of this deficiency. These informative simultaneous confidence intervals are not fully compatible with the initial multiple test, but are close to it and hence provide similar power advantages. They provide a multiple hypothesis test with strong family wise error rate control that can be used in replacement of the initial multiple test. The current paper extends previous work for informative simultaneous confidence intervals to graphical test procedures. The information gained from the newly suggested simultaneous confidence intervals is shown to be always increasing with increasing evidence against a null hypothesis. The new simultaneous confidence intervals provide a compromise between information gain and the goal to reject as many hypotheses as possible. The simultaneous confidence intervals are defined via a family of dual graphs and the projection method. A simple iterative algorithm for the computation of the intervals is provided. A simulation study illustrates the results for a complex graphical test procedure.
- 14 November 2025
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 35 (1) , 101-117
Open AccessInformative simultaneous confidence intervals for graphical test procedures
Simultaneous confidence intervals that are compatible with a given closed test procedure are often non-informative. More precisely, for a one-sided null hypothesis, the bound of the simultaneous confidence interval can stick to the border of the null hypothesis, irrespective of how far the point estimate deviates from the null hypothesis. This has been illustrated for the Bonferroni-Holm and fall-back procedures, for which alternative simultaneous confidence intervals have been suggested, that are free of this deficiency. These informative simultaneous confidence intervals are not fully compatible with the initial multiple test, but are close to it and hence provide similar power advantages. They provide a multiple hypothesis test with strong family wise error rate control that can be used in replacement of the initial multiple test. The current paper extends previous work for informative simultaneous confidence intervals to graphical test procedures. The information gained from the newly suggested simultaneous confidence intervals is shown to be always increasing with increasing evidence against a null hypothesis. The new simultaneous confidence intervals provide a compromise between information gain and the goal to reject as many hypotheses as possible. The simultaneous confidence intervals are defined via a family of dual graphs and the projection method. A simple iterative algorithm for the computation of the intervals is provided. A simulation study illustrates the results for a complex graphical test procedure.
- Open Access
Family-wise error rate control in clinical trials with overlapping populations
We consider clinical trials with multiple, overlapping patient populations, that test multiple treatment policies specifically tailored to these populations. Such designs may lead to multiplicity issues, as false statements will affect several populations. For type I error control, often the family-wise error rate (FWER) is controlled, which is the probability to reject at least one true null hypothesis. If the joint distribution of the test statistics is known, the FWER level can be exhausted by determining critical values or adjusted $α$-levels. The adjustment is typically done under the common ANOVA assumptions. However, the performed tests are then only valid under the rather strong assumption of homogeneous null effects, i.e., when the null hypothesis applies to all subpopulations and their intersections. We show that under cancelling null effects, when heterogeneous effects cancel out in some or all subpopulations, this procedure does not provide FWER control. We also suggest different alternatives and compare them in terms of FWER control and their power.
Open AccessFamily-wise error rate control in clinical trials with overlapping populations
We consider clinical trials with multiple, overlapping patient populations, that test multiple treatment policies specifically tailored to these populations. Such designs may lead to multiplicity issues, as false statements will affect several populations. For type I error control, often the family-wise error rate (FWER) is controlled, which is the probability to reject at least one true null hypothesis. If the joint distribution of the test statistics is known, the FWER level can be exhausted by determining critical values or adjusted $α$-levels. The adjustment is typically done under the common ANOVA assumptions. However, the performed tests are then only valid under the rather strong assumption of homogeneous null effects, i.e., when the null hypothesis applies to all subpopulations and their intersections. We show that under cancelling null effects, when heterogeneous effects cancel out in some or all subpopulations, this procedure does not provide FWER control. We also suggest different alternatives and compare them in terms of FWER control and their power.
- 1 October 2025
- Published by Springer Nature
- p. 79-114
Procedures with Unequally Sized Stages
- 1 October 2025
- Published by Springer Nature
- p. 327-334
Multiple Testing in Adaptive Designs